Rethinking CNS disorders: Time for new drug targets?

  • Allan V. Kalueff*
  • , Adam Michael Stewart
  • , Irving I. Gottesman
  • *Corresponding author for this work

Research output: Contribution to journalLetterpeer-review

15 Citations (Scopus)
Original languageEnglish
Pages (from-to)491-492
Number of pages2
JournalTrends in Pharmacological Sciences
Volume35
Issue number10
DOIs
Publication statusPublished - Oct 2014
Externally publishedYes

Cite this